Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Azd5492 – Application in Therapy and Current Clinical Research
Study on the Safety and Effectiveness of AZD5492 Alone or with Other ...
Azd5492 – Aplicación en terapia e investigaciones clínicas actuales
TITANium: An open-label, global multicenter phase 1/2 study of AZD5492 ...
阿斯利康「CD20×TCR×CD8三抗」在华获批临床 研究开发 | 华源医药网
阿斯利康1类新药AZD5492在中国获批临床，有望提高B细胞淋巴瘤疗效_摩熵医药
TITANium: A MULTICENTER PHASE 1/2 STUDY OF AZD5492, A FIRST‐IN‐CLASS ...
Poster - Cayatte C - Preclinical Dev of A AZD5492, CD8guided TCE For ...
tilatamig samrotecan (AZD9592) / AstraZeneca
阿斯利康1类新药AZD5492在中国获批临床，有望提高B细胞淋巴瘤疗效_摩熵医药(原药融云)
Paper: Pre-Clinical Evaluation of AZD5492, a Novel CD8-Guided T Cell ...
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and ...
Pre-Clinical Evaluation of AZD5492, a Novel CD8-Guided T Cell Engager ...
Effect of AZD8542 in an orthotopic model of pancreatic cancer with ...
AZD-5492 - Drug Targets, Indications, Patents - Synapse
AZD-5492(AZD-5492) - 药物靶点：CD20 x CD8 x TCR_在研适应症：B细胞恶性肿瘤，慢性淋巴细胞白血病，特发性 ...
阿斯利康三特异性抗体癌症新药在中国申报临床_细胞_https_研究
A Modular Phase I/II Open-label Dose Escalation and Dose Expansion ...
Novel Tri-Specific T-Cell Engager May Reduce Toxicity, Improve Safety ...
Structure of AZD3582. | Download Scientific Diagram
TCE NewCo，再度起风了 - 知乎
B-cell depletion. Freshly isolated PBMCs were incubated for two days ...
Schematic diagram showing the molecular mechanism by which the SR-4835 ...
阿斯利康(AZN.US)三抗新药在中国再获批临床 拟用于治疗系统性红斑狼疮等_腾讯新闻
How does AstraZeneca's PARP inhibitor differentiate?
AstraZeneca leads the development of small molecule RXFP1 agonists
Results of a Phase 1b, Open-label, Multicenter Study of Selgantolimod ...
2022年美国淋巴瘤最新治疗新药盘点 | 淋巴瘤最新治疗进展 _美联医邦
AstraZeneca’s TITANium Study: A New Hope for B-Cell Malignancies ...
ISSX 2022 - Hypha Discovery
ChemAIRS to Investigate Synthesis Plan for AZD5462: A RXFP1 Agonist for ...
Viruses A549 Cells | ATCC | Bioz
Small Molecule Highlights #24 – April 2024 – Dalriada Drug Discovery
Study on Selpercatinib for Adults with Advanced or Metastatic Solid ...
Webinar «Post EHA-ISTH 2024» - Sociedad Española de Trombosis y Hemostasia
Bronchiolitis obliterans syndrome – Overview of Information and ...
Molecular characterization and cytotoxic effects of AZD5363, AZD8542 ...
ENG BC 7600 Series Brochure | PDF | Hematology | Tissue (Biology)
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in ...
HSD3B2 antibody (67572-1-Ig) | Proteintech
